Remodulin for the treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN)
IRB
CHLA-16-00033
Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study
To explore the safety and treatment effect of intravenous (IV) Remodulin as add on therapy in neonates with PPHN compared to placebo.
Coordinator Contact
Sharon Tang
Contact Email
shatang@chla.usc.edu